Neurotechnology startup Mave Health has raised $2.1 million (about ₹18 crore) in a seed round led by Blume Ventures, signalling strong investor confidence in India’s fast-growing healthtech sector. The round included participation from Inuka Capital, Stanford Angels, founders of Groww, Aureolis Ventures, Raymond Russell, Juhi Bhatnagar of Forj Capital and existing backer All In Capital, which increased its stake.
Technology-driven approach to mental healthcare
Founded to transform mental healthcare in India, Mave Health develops solutions that combine neuroscience, wearable devices and personalised care. The company targets conditions such as depression with non-invasive neurotechnology integrated into structured, therapist-supported wellness programmes.
Its flagship product is a brain-stimulation wearable paired with guided therapy and continuous human support, aiming to shift care from reactive interventions to proactive, evidence-based management of mental well‑being.
Use of funds and expansion plans
The fresh capital will be deployed to enhance product features, scale technology infrastructure and expand distribution across India. Mave Health plans to bolster hiring in research, product development and clinical roles to meet rising demand for digital mental health solutions.
Funding history and market traction
This seed round follows a roughly $750,000 pre-seed raise in November 2023, reflecting steady investor interest in the startup’s progress. Mave Health has reported early traction as awareness of mental health grows in India while access to quality care remains constrained.
By combining neuroscience-backed tools with personalised programmes, the company seeks to differentiate itself in an evolving market where scalable, technology-enabled interventions are increasingly valued.
Investor sentiment and sector outlook
Blume Ventures’ lead investment aligns with its strategy of backing early-stage companies addressing large-scale problems through technology. The firm has been active across healthtech, fintech and deeptech, and this deal underscores continued investor focus on mental health startups leveraging AI, neurotech and digital delivery models.
The road ahead for mental health in India
Rising stress, urban lifestyle pressures and greater public awareness are expected to drive growth in India’s mental health market. Startups such as Mave Health aim to narrow the gap between clinical care and everyday, accessible solutions, potentially reshaping care pathways from stigma-driven silence to technology-enabled, evidence-informed support.
